Journal of Vascular Surgery

Syndicate content
Journal of Vascular Surgery RSS feed.
Updated: 5 days 17 hours ago

LEV 5. A Comparison of 1470-nm Endovenous Laser Ablation and Radiofrequency Ablation in the Treatment of Great and Small Saphenous Vein Insufficiency

31 October 2018 - 11:00pm
The primary treatment of varicose veins was surgery for many years, although thermal ablation techniques have become increasingly popular in recent years. Endovenous laser ablation (EVLA) and radiofrequency ablation (RAF) are safe and minimally invasive techniques used in the treatment of saphenous vein insufficiency. The objective of this study was to compare 1470-nm EVLA and RAF (VNUS ClosureFast; Covidien, Mansfield, Mass) in the treatment of patients with great and small saphenous vein insufficiency.

LEV 4. Adherence to Medical Treatment in Chronic Venous Disease in a Public Hospital in Mexico

31 October 2018 - 11:00pm
The objective of this study was to determine the percentage of patients who adhere to medical treatment for chronic venous disease in a first-time visit to the vascular surgery and angiology department of the Hospital General de México “Dr Eduardo Liceaga” and to determine the principal causes of treatment abandonment.

LEV 3. Outcomes of Ultrasound-Guided Catheter-Directed Foam Sclerotherapy With or Without Perivenous Tumescent Enhancement in the Treatment of Great Saphenous Vein Reflux

31 October 2018 - 11:00pm
Great saphenous vein reflux is widely managed by endovenous methods as first-line treatment. Sclerotherapy is a recommendation when other endovenous treatments are not suitable. Tumescent anesthesia is used in other endovenous thermal treatments to help with vein compression around the catheter for better contact and to prevent heat damage. In developing countries like Thailand, the costs of the standardized instruments, such as radiofrequency ablation and endovenous laser, are high. Not many patients can afford such treatments.

LEV 2. Preliminary First in Human Ultrasound-Guided High-Intensity Focused Ultrasound Treatment in Superficial Lower Limb Veins

31 October 2018 - 11:00pm
High-intensity focused ultrasound (HIFU) is an alternative to surgery or other thermal methods widely used in the treatment of thyroid, breast fibroadenoma, and uterine fibroma.

LEV 1. Transilluminated Powered Phlebectomy Using Second-Generation Trivex Technology Under Tumescent Anesthesia Only: Are the Patients Satisfied With the Procedure and Its Outcome?

31 October 2018 - 11:00pm
The purpose of the study was to assess the Venous Clinical Severity Score (VCSS) and patients’ satisfaction after use of the second-generation Trivex (LeMaitre Vascular, Burlington, Mass), a device used for transilluminated powered phlebectomy. The group of patients selected for the procedure in our department had legs with a large number of varices, some with previous vein surgery or a previous episode of superficial thrombophlebitis. The majority of the patients were overweight. Alternative treatments for these selected patients have suboptimal results at best.

VCI 2. A Single-Center Experience Using Intravascular Ultrasound as an Adjunct in Nutcracker Syndrome

31 October 2018 - 11:00pm
The nutcracker syndrome is an uncommon condition but with high morbidity, leading even to chronic renal failure when it is not treated. Endovascular treatment is now the most popular approach, but some related complications, such as stent migration, have been described.

VCI 1. Is the Nutcracker Syndrome the Most Important Actor in the Presence and Presentation of the Pelvic Congestion Syndrome?

31 October 2018 - 11:00pm
The objective of this study was to show a discrepancy in the real causes of the pelvic congestion syndrome. In our experience obtained in the Central Military Hospital, Mexico City, a hospital of the highest level in the Mexican armed forces with >700 hundred beds, we have found a great discrepancy in what has been published around the world concerning the nutcracker syndrome as the main cause of the pelvic congestion syndrome.

AVA 3. Efficacy of Staged Brachial Artery-Basilic/Brachial Vein Elevation Arteriovenous Fistula (Axillary Vein Saved)

31 October 2018 - 11:00pm
Brachial artery-basilic/brachial vein (Br-Ba/Br) transposition arteriovenous fistula (AVF) has emerged as an autologous AVF, but there have been few reports on the outcomes of Br-Ba/Br elevation AVF instead of conventional transposition. We evaluated efficacy of staged Br-Ba/Br elevation AVF and compared clinical outcomes of Br-Ba and Br-Br elevation AVF.

AVA 2. Neuromuscular Electrostimulation: A New Therapeutic Option to Improve Radiocephalic Arteriovenous Fistula Maturation in End-Stage Chronic Kidney Disease Patients

31 October 2018 - 11:00pm
Radiocephalic arteriovenous fistula (RCAVF) is the “gold standard” vascular access for end-stage chronic kidney disease patients. Exercises after AVF creation improve maturation. No articles regarding neuromuscular electrostimulation (NMES) in AVF maturation have been published.

AVA 1. Salvage of Failing Native Arteriovenous Fistula by Interwoven Nitinol Stenting: A Review of Early Experience

31 October 2018 - 11:00pm
Percutaneous angioplasty remains the most commonly employed method for treatment of native arteriovenous access stenosis. There is growing evidence that demonstrates benefit with covered stenting of recalcitrant stenosis in patients with an arteriovenous graft. Currently, the use of either bare-metal stents or covered stents in patients with native arteriovenous fistulas (AVFs) is not considered a first-line intervention. This case series aimed to examine the clinical effectiveness and feasibility of interwoven nitinol stenting in the salvage of failing AVFs.

LEA26. Use of Thrombolysis in Acute Lower Extremity Ischemia With Known Distal Target Vessel for Revascularization Stenting

31 October 2018 - 11:00pm
Thrombolysis is an important therapeutic tool in localizing a distal arterial target vessel in patients presenting with acute lower extremity ischemia. In some patients, however, thrombolysis fails to identify a suitable target vessel for lower extremity bypass, often resulting in amputation. Pre-existing knowledge of the distal target vessel may obviate the need for thrombolytic-mediated distal arterial recanalization. We report our 5-year experience in managing patients with acute lower extremity ischemia with a known distal arterial target vessel without thrombolytic therapy.

LEA 25. Outcomes in Limb Preservation After Revascularization and Minor Amputations in 876 Patients With Peripheral Arterial Disease During a 9-Year Period

31 October 2018 - 11:00pm
The objective of this study was to review limb preservation outcomes after revascularization and minor amputations in patients with peripheral arterial disease in an Asian population.

LEA 24. Toe Pressure in Predicting Diabetic Foot Ulcer Healing: A Systematic Review and Meta-Analysis

31 October 2018 - 11:00pm
There is a significant body of evidence supporting the clinical utility of toe systolic blood pressure (TBP) as an indicator of peripheral blood flow in diabetic foot ulcers (DFUs) and consequently in predicting healing capacity. However, there is still little consensus in the literature on the relevant cutoff values. This systematic review seeks to evaluate the sensitivity and specificity of toe pressure measurements in prediction of DFU wound healing and to investigate for a cutoff value to predict healing as supported by current evidence.

LEA 23. The 12-Month Results of the EffPac Trial

31 October 2018 - 11:00pm
The aim of the investigator-initiated Effectiveness of Paclitaxel-coated Luminor Balloon Catheter vs Uncoated Balloon Catheter in the Superficial Femoral and Popliteal Arteries to Prevent Vessel Restenosis or Reocclusion (Effpac) trial was to evaluate the safety and efficacy of the Luminor paclitaxel-coated drug-eluting balloon (DEB; iVascular, Barcelona, Spain) in inhibiting restenosis and in ensuring long-term patency. A homogeneous distribution of paclitaxel 3 μg/cm2 on the balloon’s surface is applied by a proprietary TransferTech coating technology.

LEA 22. Totally Percutaneous Femoral-Popliteal Bypass: The Best of Both Worlds

31 October 2018 - 11:00pm
Endovascular techniques are now leading the revascularization of lower limbs, mainly because of the interest in a percutaneous approach. Despite huge progress, failure of recanalization may occur, or more often, recurrence darkens the evolution. In these cases, surgical bypasses are required, but they have a higher morbidity and mortality impact. We describe an innovative technique of femoral-popliteal bypass realized through a totally percutaneous approach and the early results of the initial study.

LEA 21. Emergency Implantation of Bentley’s BeGraft Stent Graft System in the Management of Vessels Injuries: Preliminary Results

31 October 2018 - 11:00pm
Endovascular treatment of vessel injuries with stent graft is the treatment of choice in patients not suitable for embolization or at high-risk for surgery. The aim of our study was to evaluate the efficacy and the safety of Bentley’s BeGraft Peripheral Stent Graft System (Bentley Innomed GmbH, Hechingen, Germany) for emergency endovascular treatment of vessels injuries.

LEA 20. Aneurysm of Persistent Sciatic Artery With Acute Lower Limb Ischemia—Hybrid Approach in Management

31 October 2018 - 11:00pm
This article reports the hybrid approach in management of a rare case of partially thrombosed persistent sciatic artery (PSA) aneurysm in a patient who presented with acute left lower limb ischemia due to embolization.

LEA 19. Long-Term Follow-up in Extreme Endovascular Revascularization of Native Artery After Bypass Failure in Patients With Critical Limb Ischemia

31 October 2018 - 11:00pm
Lower extremity bypass (graft) failure in patients with limb-threatening ischemia carries an amputation rate of >50%. Redo bypass grafting is associated with an inferior outcome compared with primary bypass and is often not feasible because of the patient’s medical risk factors and lack of adequate bypass conduit or target. Considerable advances in interventional skills and the new devices available allow an endovascular approach to arterial lesions previously confined to bypass surgery. The aim of this study was to evaluate the role of endovascular recanalization of severely diseased native arteries after bypass occlusion in patients with critical limb ischemia (CLI) and its outcomes.

LEA 18. Safety of Outpatient Lower Extremity Endovascular Intervention in Diabetic Peripheral Vascular Disease: A Single-Center Experience

31 October 2018 - 11:00pm
Atherosclerotic peripheral arterial disease involving the lower limbs is a common disease associated with a high probability of morbidity and mortality, with two to six times higher incidence of both cardiovascular and cerebrovascular disease. After percutaneous intervention, patients have traditionally been kept for overnight observation. Time to ambulation and hospital stay have decreased by virtue of dramatic improvement of endovascular equipment with low-profile devices as well as arterial closure devices.

LEA 17. Better Results Are Obtained With the New C-Guard Stent

31 October 2018 - 11:00pm
Recently, InspireMD (Tel Aviv, Israel) presented the new InspireMD CGuard, a bare-metal stent covered by a micron-level mesh (MicroNet). The aim of this study was to evaluate the immediate and midterm outcomes of this new device compared with the results obtained with the first CGuard type (smaller diameter, higher flexibility, smoother tip) in terms of operative complications.